Difference between revisions of "HL7 Study Participation and Patient Narrative/CDA DSTU Draft Testing Plan"

Revision as of 19:51, 29 March 2012

Revision as of 19:48, 29 March 2012 (view source) Callard (talk \| contribs) ← Older edit		Revision as of 19:51, 29 March 2012 (view source) Callard (talk \| contribs) (Replaced content with "PTNarr-1572-testing-plan-draft.pdf") Newer edit →
Line 1:		Line 1:
−	As part of FDA’s ongoing study data standards research and development activities, FDA is planning to test the use of the HL7 Study Participation standard (currently a Draft Standard for Trial Use – DSTU) and the HL7 Clinical Document Architecture, Release 2 (CDA R2) normative standard. Please see http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm269946.htm for more information.	+	[[PTNarr-1572-testing-plan-draft.pdf]]
−
−	[[~~Media:~~ PTNarr-1572-testing-plan-draft.pdf]]